The diagnosis of CLL includes having positive immunophenotypes of lymphocytes (CD19, CD20, CD23 and CD5) and this was proven in the patient’s tissue biopsy. The gene discussed is CD5; the disease is B-cell chronic lymphocytic leukemia.